This is an incredible distinction acknowledging leaders and organizations improving care, achieving measurable results, and transforming the healthcare industry. Baldwin seeks to link laboratory research with clinical results at the Philadelphia cancer center. He started a pathology task force and partnered on a unit to collect and validate diagnostic tools. He also led the development and implementation of a screening panel allowing physicians at the center to analyze more than 1,500 cancer-related genes. With the information they gather, they can tailor treatment options to patients and boost the chances of success. The tool, known as "Comprehensive Cancer Panel version 2," is used for almost every lung, blood, melanoma or sarcoma cancer patient. As of January, more than 5,400 tumors had been screened.